Effect of tamoxifen on bone mineral density and blood lipids in ovariectomized rats

Polish Journal of Pharmacology

Volumn 55, Issue 6, 2003, Pages 1137-1142

  Czerny, Bogusław ^a   Pawlik, Andrzej ^a   Juzyszyn, Zygmunt ^a   Myśliwiec, Zofia ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Bone; Lipid metabolism; Tamoxifen

Indexed keywords

CHOLESTEROL; DRUG VEHICLE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAMOXIFEN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG SCREENING; FEMALE; FEMUR; LIPID BLOOD LEVEL; LIPID METABOLISM; NONHUMAN; OVARIECTOMY; PREVENTION; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE;

ANIMALS; BONE AND BONES; BONE DENSITY; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; LIPIDS; OVARIECTOMY; RATS; RATS, WISTAR; TAMOXIFEN; TRIGLYCERIDES;

EID: 1642462153     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Cauley J.A., Seeley D.G., Ensrud K., Ettinger B., Black D., Cummings S.R.: Estrogen replacement therapy and fractures in older women. Ann. Intern. Med., 1995, 122, 9-16.
2. Fentiman C., Rodin A., Murby A., Fogelman I.: Bone mineral content of women receiving tamoxifen for mastalgia. Brit. J. Cancer, 1989, 60, 262-264.
3. Fisher B., Redmond C.: New perspective on cancer of the contralateral breast: a marker for assessing tamoxifen as a preventive agent. J. Nat. Cancer Inst., 1991, 83, 1278-1280.
4. Foresta C., Ruzza G., Mioni R., Guarnei G., Gribaldo R., Meneghello A., Mastrogiacomo I.: Osteoporosis and decline of gonadal function in the elderly male. Hormone Res., 1984, 19, 18-22.
5. Gurkan L., Ekeland A., Gautivik K.M., Langeland N., Ronningen H., Solheim L.F.: Bone changes after castration in rats: a model of osteoporosis. Acta Orthop. Scand., 1986, 57, 67-70.
6. Hietala E.L.: The effect of ovariectomy on periosteal bone formation and bone resorption in adult rats. Bone Miner., 1993, 20, 57-65.
7. Jordan V.C., Fritz N.F., Langan-Fahey S., Thompson M., Tormey D.C.: Alteration of endocrine parameters in premenopausal women with breast cancer long-term adjuvant therapy with tamoxifen as a single agent. J. Nat. Cancer Inst., 1991, 83, 1488-1491.
8. Kalu D.N., Liu C.C., Hardin R.R., Hollis B.W.: The aged rat model of ovarian hormone deficiency bone loss. Endocrinology, 1989, 124, 7-16.
9. Kanis J.A., Melton III L.J., Christiansen C., Johnson C.C., Khaltaev N.: The diagnosis of osteoporosis. J. Bone Miner. Res., 1994, 9, 1137-1141.
10. Kobayashi S., Inoue S., Hosoi T., Ouchi Y., Shiraki M., Orimo H.: Association of bone mineral density with polymorphism of the estrogen receptor gene. J. Bone Miner. Res., 1996, 11, 306-311.
11. Love R.R., Mazess R.B., Barden H.S., Epstein S., Newcomb P.A., Jordan V.C., Carbone P.P., DeMets D.L.: Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N. Engl. J. Med., 1991, 326, 852-856.
12. Love R.R., Wiebe D.A., Newcomb P.A., Cameron L., Leventhal H., Jordan V.C., Feyzi J., DeMets D.L.: Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann. Inter. Med., 1991, 115, 860-864.
13. Morris H.A., Porter S.J., Durbridge T.C., Moore R.J., Need A.G., Nordin B.E.C.: Effects of ovariectomy on biochemical and bone variables in the rat. Bone Miner., 1992, 18, 133-142.
14. Nayfield S.G., Kay J.E., Forll L.G., Dorr F.A., Kramer B.S.: Potential role of tamoxifen in prevention of breast cancer. J. Nat. Cancer Inst., 1991, 83, 1450-1459.
15. Nordin B.E.C., Morris H.A.: The calcium deficiency model for osteoporosis. Nutr. Rev., 1989, 47, 65-72.
16. Prentice R.L.: Tamoxifen as a potential preventive agent in healthy postmenopausal women. J. Nat. Cancer Inst., 1990, 82, 1310-1311.
17. Riggs B.L., Melton III L.J.: The prevention and treatment of osteoporosis. N. Engl. J. Med., 1992, 327, 620-627.
18. Rutqvist L.E., Cedermerk B., Glos U.: Contralateral primary tumors in breast cancer patients in a random trial adjuvant therapy: J. Nat. Cancer Inst., 1991, 83, 1299-1306.
19. Sata M., McClintock C., Kim J., Turner C.H., Bryant H.U., Mage D., Slemenda C.W.: Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats. J. Bone Miner. Res., 1994, 9, 715-724.
20. Sims N.A., Morris H.A., Moore R.J., Durbridge T.C.: Parathyroidectomy does not prevent bone loss in the ovariectomised rat. J. Bone Miner. Res., 1994, 9, 1859-1864.
21. Srivastavs T.A., Baumann D., Schonfeld G.: In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse. Eur. J. Biochem., 1993, 216, 527-538.
22. Stepan J.J., Lachman M., Zverina J., Pacovsky V., Baylink D.J.: Castrated man exhibits bone loss: effects of calcitonin treatment on biochemical indices of bone remodeling. J. Clin. Endocrionol. Metab., 1989, 69, 523-527.
23. Stock J.L., Coderre J.A., Burke E.M., Danner D.B., Chipman S.D., Shapiro R.J.: Identification of estrogen receptor mRNA and the estrogen modulation of parathyroid hormone stimulated cyclic AMP accumulation in opossum kidney cells. J. Cell. Physiol., 1992, 150, 517-525.
24. Turner R.T., Riggs B.L., Spelsberg T.C.: Skeletal effects of estrogen. Endocrine Rev., 1994, 15, 275-300.
25. Westerlind K.C., Gibson K.J., Malone P., Evans G.L., Turner R.T.: Differential effects of estrogen metabolites and reproductive tissues of ovariectomised rats. J. Bone Miner. Res., 1998, 13, 1023-1031.
26. Wronski T.J., Cintron M., Dann L.M.: Temporal relationship between bone loss and increased bone turnover in ovariectomised rats. Calcified Tissue Int., 1988, 43, 179-183.
27. Wronski T.J., Dann L.M., Scott K.S., Cintron M.: Long-term effects of ovariectomy and aging on the rat skeleton. Calcified Tissue Int., 1989, 45, 360-366.